Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658731 · ClinicalTrials.gov registry record · NA

Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients

A NA study of Head and Neck Cancer and Brain Tumor, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Recruiting
Registry status
NA
Development phase
338
Enrollment target
2
Study locations

NCT05658731: Recruiting NA study of Head and Neck Cancer and Brain Tumor, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

NCT05658731 is a NA study of Head and Neck Cancer and Brain Tumor that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 338 participants, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (31% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658731, a NA study of Head and Neck Cancer and Brain Tumor, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

RECRUITING
Registry status
NA
Development phase
338 participants
Enrollment target
2
Study locations

Study Summary

The goal of this trial is to determine whether it is possible to minimize radiation dose to parts of the brain that are important for thinking and learning in children who require radiation to treat their tumor, and if this will help reduce neurocognitive (thinking and learning) impairments in these patients. Patients with newly diagnosed brain or head and neck tumors who are having radiation therapy will have neurocognitive testing and MRI imaging (both research and for regular care) done as part of their participation in the study. Survivors of childhood brain tumors who completed radiation therapy at least two years before joining the study, and have not had a recurrence, will have neurocognitive testing and research MRIs completed. Healthy children will also be enrolled and have research MRIs done. The researchers will use the radiation plan to determine how much radiation was delivered to different parts of the brain. The investigators will use the MRIs to determine how the normal brain is changing after treatment; and how this compares to patients who had standard radiation treatment or who never had a brain tumor. The neurocognitive testing will be compared among different groups to see how different treatment plans affect performance on neurocognitive tests.

Primary Outcome

Number of plans that meet substructure-informed constraints (per protocol) divided by the total number of plans.

Interventions

  • DIAGNOSTIC_TEST MRI
  • RADIATION substructure informed planning
  • OTHER Neurocognitive Testing

Study Locations (2)

District of Columbia

  • Sibley Memorial Hospital - Washington D.C.

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2023-05-17
Est. Completion 2035-12
Phase NA

What NCT05658731 shows while recruiting

NCT05658731 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, above the 259-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (31% higher).

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which MRI is the first listed.

NCT05658731 reports a single indexed study location in District of Columbia, Maryland.

Frequently Asked Questions

What is clinical trial NCT05658731 about?

NCT05658731 is a clinical study titled "Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients". The goal of this trial is to determine whether it is possible to minimize radiation dose to parts of the brain that are important for thinking and learning in children who require radiation to treat their tumor, and if this will help reduce neurocognitive (thinking and learning) impairments in these...

What is the current status of trial NCT05658731?

This trial is currently recruiting. It is a NA study. The enrollment target is 338 participants. The study started on 2023-05-17. Estimated completion is 2035-12.

What conditions does trial NCT05658731 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Brain Tumor.

What interventions are being tested in trial NCT05658731?

The interventions under investigation include: MRI (DIAGNOSTIC_TEST), substructure informed planning (RADIATION), Neurocognitive Testing (OTHER).

Who is sponsoring clinical trial NCT05658731?

This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05658731 being conducted?

This trial has 2 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05658731's enrollment target sits among peer trials

338 30th of 250 higher than 221 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03253263 · 338 participants · Phase 2

    A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

  • NCT06022939 · 338 participants · Phase 3

    Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05658731, the US trial registry maintained by the National Library of Medicine. NCT05658731 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.